BioInvent International AB   Report issue

For profit Phase 1 Phase 2
Founded: Lund Sweden (1996)

Organization Overview

First Clinical Trial
2007
NCT00612196
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

BioInvent International AB